Trial intelligence / Profile preview

Precedex vs Propofol for Emergence in Craniotomy

NCT00848991Phase 3Completed

Sponsor
Cooper University Health Care
Start
Feb 2009
Primary completion
Feb 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of dexmedetomidine in brain tumor, sponsored by Cooper University Health Care. Started Feb 2009; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

brain tumor

Beyond the preview

Go deeper on NCT00848991.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00848991.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call